CI 10-Q Quarterly Report March 31, 2024 | Alphaminr
ALPHAMINR

CI 10-Q Quarter ended March 31, 2024

Balance Sheet
Cash Flow
Income Statement
Debt
TABLE OF CONTENTS
Part IItem 1. Financial StatementsNote 1 Description Of BusinessNote 2 Summary Of Significant Accounting PoliciesNote 3 Accounts Receivable, NetNote 4 Supplier Finance ProgramNote 5 Assets and Liabilities Of Businesses Held For SaleNote 6 Earnings Per ShareNote 7 DebtNote 8 Common and Preferred StockNote 9 Insurance and Contractholder LiabilitiesNote 10 ReinsuranceNote 11 InvestmentsNote 12 Fair Value MeasurementsNote 13 Variable Interest EntitiesNote 14 Accumulated Other Comprehensive Income (loss)Note 15 Income TaxesNote 16 Contingencies and Other MattersNote 17 Segment InformationItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationPart IIItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 5. Other InformationItem 6. Exhibits

Exhibits

3.1 Restated Certificate of Incorporation of The Cigna Group Filed by the registrant as Exhibit 3.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2023 and incorporated herein by reference. 3.2 Amended and Restated By-laws of The Cigna Group Filed by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023 and incorporated herein by reference. 4.1 Supplemental Indenture No. 7, dated as of February 13, 2024,between The Cigna Group and U.S. Bank Trust Company, National Association, as trustee Filed by the registrant as Exhibit 4.1 to the Current Report on Form 8-K on February 13, 2024 and incorporated herein by reference. 10.1 Offer Letter for Eric P. Palmer dated January 16, 2024 Filed by the registrant as Exhibit 10.23 to the Annual Report on Form 10-K for the period ended December 31, 2023 and incorporated herein by reference. 10.2 Offer letter for Brian Evanko dated January 16, 2024 Filed by the registrant as Exhibit 10.26 to the Annual Report on Form 10-K for the period ended December 31, 2023 and incorporated herein by reference. 31.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 31.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 32.1 Certification of Chief Executive Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith. 32.2 Certification of Chief Financial Officer of The Cigna Group pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith.